Literature DB >> 30264827

Treatment as Prevention for HIV Infection: Current Data, Challenges, and Global Perspectives

Jean C Yombi1, Helena Mertes2.   

Abstract

In 2008, the Swiss National AIDS Commission issued a statement about the safety of HIV treatment in terms of reduced transmission in serodiscordant couples to reduce transmission in serodiscordant couples. This was subjected to debate until 2011 when the HIV prevention trial network 052 published the first randomized study about HIV transmission in serodiscordant couples, where no transmission was observed when the infected person was under effective antiretroviral treatment (ART). Later, the Partners of People on ART-A New Evaluation of the Risks (PARTNER) and the opposites attract studies, which first involved a large number of men who have sex with men (MSM), also showed no transmission, even in condomless receptive anal intercourse (CLAI). In this article, we first review the major studies' data showing the efficacy of ART in HIV transmission in serodiscordant couples at public health scale. Second, we discuss the implications and challenges behind the treatment as prevention strategy regarding the 90-90-90 UNAIDS targets to end the HIV epidemic.We now have strong evidence that ART reduces the risk of transmission of HIV from a positive partner to their negative partner. However, far beyond ART, combining prevention policies is crucial to avoid a new increase in the overall HIV incidence. Copyright:
© 2018 Permanyer.

Entities:  

Keywords:  90-90-90; HIV; Serodiscordant couples; Sexual transmission; Treatment as Prevention (TasP)

Mesh:

Substances:

Year:  2018        PMID: 30264827     DOI: 10.24875/AIDSRev.M18000024

Source DB:  PubMed          Journal:  AIDS Rev        ISSN: 1139-6121            Impact factor:   2.500


  8 in total

1.  Psychosocial support for HIV serodiscordant couples.

Authors:  Constance Matshidiso Lelaka; Idah Moyo; Livhuwani Tshivhase; Azwihangwisi Helen Mavhandu-Mudzusi
Journal:  Health Psychol Behav Med       Date:  2022-06-16

2.  Are We Ready for NGS HIV Drug Resistance Testing? The Second "Winnipeg Consensus" Symposium.

Authors:  Hezhao Ji; Paul Sandstrom; Roger Paredes; P Richard Harrigan; Chanson J Brumme; Santiago Avila Rios; Marc Noguera-Julian; Neil Parkin; Rami Kantor
Journal:  Viruses       Date:  2020-05-27       Impact factor: 5.048

3.  Bibliometric analysis of research on the effects of human immunodeficiency virus in orthopaedic and trauma surgery.

Authors:  Ciaran Brennan; Maritz Laubscher; Sithombo Maqungo; Simon Matthew Graham
Journal:  World J Orthop       Date:  2021-03-18

4.  Biopsychosocial approach to understanding determinants of depression among men who have sex with men living with HIV: A systematic review.

Authors:  Zul Aizat Mohamad Fisal; Halimatus Sakdiah Minhat; Nor Afiah Mohd Zulkefli; Norliza Ahmad
Journal:  PLoS One       Date:  2022-03-14       Impact factor: 3.240

Review 5.  Overview of the Analytes Applied in Genotypic HIV Drug Resistance Testing.

Authors:  Hezhao Ji; Paul Sandstrom
Journal:  Pathogens       Date:  2022-06-29

Review 6.  Antiviral potential of natural products from marine microbes.

Authors:  Mengqi Yi; Sixiao Lin; Bin Zhang; Haixiao Jin; Lijian Ding
Journal:  Eur J Med Chem       Date:  2020-08-31       Impact factor: 6.514

7.  Significance of Increased Rapid Treatment from HIV Diagnosis to the First Antiretroviral Therapy in the Recent 20 Years and Its Implications: the Korea HIV/AIDS Cohort Study.

Authors:  Yoon Jung Kim; Shin Woo Kim; Ki Tae Kwon; Hyun Ha Chang; Sang Il Kim; Youn Jeong Kim; Min Ja Kim; Jun Yong Choi; Hyo Youl Kim; June Myung Kim; Bo Youl Choi; Bo Young Park; Yun Su Choi; Mee Kyung Kee; Myeong Su Yoo; Jung Gyu Lee
Journal:  J Korean Med Sci       Date:  2019-10-07       Impact factor: 2.153

8.  A province-wide HIV initiative to accelerate initiation of treatment-as-prevention and virologic suppression in British Columbia, Canada: a population-based cohort study.

Authors:  Ni Gusti Ayu Nanditha; Xinzhe Dong; Hiwot M Tafessu; Lu Wang; Michelle Lu; Rolando Barrios; Julio S G Montaner; Viviane D Lima
Journal:  CMAJ Open       Date:  2022-01-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.